304853-89-2

Basic information

• Product Name: 2-(2-AMINO-5-BROMOPHENYL)PROPAN-2-OL
• Synonyms: 2-(2-AMINO-5-BROMOPHENYL)PROPAN-2-OL
• CAS NO: 304853-89-2
• Molecular Formula: C₉H₁₂BrNO
• Molecular Weight: 230.1
• Mol File: 304853-89-2.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 311.2±27.0 °C(Predicted)
• Appearance: /
• Density: 1.478±0.06 g/cm3(Predicted)
• PKA: 14.27±0.29(Predicted)
• CAS DataBase Reference: 2-(2-AMINO-5-BROMOPHENYL)PROPAN-2-OL(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-AMINO-5-BROMOPHENYL)PROPAN-2-OL(304853-89-2)
• EPA Substance Registry System: 2-(2-AMINO-5-BROMOPHENYL)PROPAN-2-OL(304853-89-2)

Safety Data

• Hazardous Substances Data: 304853-89-2(Hazardous Substances Data)

Usage

Synonyms

2-amino-5-bromobenzyl alcohol

Physical Appearance

White to light yellow solid

Functional Groups

Hydroxyl (OH), amine (NH2), and bromine (Br) atom

Classification

Alcohol

Uses

Synthesis of pharmaceuticals and other organic compounds; versatile building block in organic synthesis for the production of various pharmaceutical and biologically active compounds

Safety

Handle with care, as it can be hazardous if not used properly.

Upstream product

• 52727-57-8 5-bromo-2-aminobenzoic acid methyl ester 
• 104670-74-8 methyl 2-amino-3-bromobenzoate 
• 75-16-1 methylmagnesium bromide 
• 29124-56-9 1-(2-amino-5-bromophenyl)ethanone 
• 917-54-4 methyllithium 
• 63243-76-5 2-amino-5-bromobenzoic acid,ethyl ester 
• 5794-88-7 5-Bromo-2-aminobenzoic acid 

Downstream Products

• 304853-34-7 6-Bromo-4,4-dimethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-thione 
• 865670-73-1 N-[4-bromo-2-(1-hydroxy-1-methylethyl)phenyl]-2-chloroacetamide 
• 304858-44-4 6-bromo-2,4,4-trimethyl-1,4-dihydro-2H-1,3-benzoxazine 
• 304858-51-3 6-bromo-4,4-dimethyl-2-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazine 
• 304854-07-7 5-(4,4-Dimethyl-2-oxo-1,4-dihydro-2H-benzo [d] [1,3]oxazin-6-yl)-2-fluoro-benzonitrile 
• 304853-30-3 PRA-910 
• 304854-45-3 6-(3-Chloro-4-fluoro-phenyl)-4,4-dimethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one 
• 304854-09-9 6-(3-Chloro-5-fluoro-phenyl)4,4-dimethyl-1,4-dihydro-benzo[d] [1,3]oxazin-2-one 
• 304853-36-9 3-(4,4-dimethyl-2-oxo-1,4-dihydro-2H-benzo[d][1,3]oxazin-3-yl)benzonitrile 
• 304854-26-0 6-(3-Fluoro-phenyl)-4,4-dimethyl-1,4-dihydro-benzo[d] [1,3]-oxazin-2-one 
• 304854-36-2 6-(3-Methoxy-phenyl)4,4-dimethyl-1,4-dihydro-benzo [d] [1,3]-oxazin-2one 
• 305799-74-0 6-(4-Chloro-phenyl)-4,4-dimethyl-1,4-dihydro-benzo [d] [1,3]-oxazin-2-one 
• 304854-37-3 6-(2-chloro-phenyl)-4,4-dimethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one 
• 304853-28-9 6-(3-chlorophenyl)-4,4-dimethyl-1,4-dihydro-2H-benzo[d][1,3]oxazine-2-one 

Relevant articles and documents

Heterocyclic com pounds and organic light-emitting diode including the same

The present invention relates to a novel heterocyclic compound and an organic light emitting element including the same as a light-emitting material and, more specifically, to a heterocyclic compound having excellent light emission properties, such as a driving voltage, luminous efficiency, and lifetime, and an organic light emitting element including the same. Since the heterocyclic compound according to the present invention is more stable compared to conventional materials and has the excellent light emission properties for a driving voltage or current efficiency, the organic light emitting element including the same can be driven with a low-voltage and light emission efficiency can be improved.

SUBSTITUTED BENZO[d][1,3]OXAZIN-2(4H)-ONES AND RELATED DERIVATIVES AND THEIR USES FOR MODULATING THE PROGESTERONE RECEPTOR

Compounds of formula (I), or pharmaceutically acceptable salts thereof, are provided, wherein R1-R6 and X are defined herein. Also provided are methods of preparing the compounds of formula (I), pharmaceutical compositions and kits containing a compound of formula (I), as are methods of treating endometriosis, hormone-dependent carcinomas, leiomyoma, fibroids, dysfunctional bleeding, polycystic ovary syndrome, and menopause related symptoms; methods of contraception; methods of providing hormone replacement therapy; methods of stimulating food intake; methods of synchronizing estrus; and methods of treating symptoms of premenstrual syndrome and premenstrual dysphoric disorder by administering to a mammal in need thereof a pharmaceutically effective amount of a compound of formula (I).

1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5′-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators

A series of novel 7-(5′-cyanopyrrol-2-yl) substituted benzo[1,4]oxazepin-2-ones were prepared and tested for their progesterone receptor (PR) agonist or antagonist activity in the alkaline phosphatase assay using the human T47D breast carcinoma cell line.